Traws Pharma, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRAW and other ETFs, options, and stocks.

About TRAW

Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. 

CEO
Iain David Dukes
CEOIain David Dukes
Employees
7
Employees7
Headquarters
Newtown, Pennsylvania
HeadquartersNewtown, Pennsylvania
Founded
1998
Founded1998
Employees
7
Employees7

TRAW Key Statistics

Market cap
6.51M
Market cap6.51M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
—
Dividend yield—
Average volume
235.81K
Average volume235.81K
High today
$1.29
High today$1.29
Low today
$0.99
Low today$0.99
Open price
$1.08
Open price$1.08
Volume
517.00K
Volume517.00K
52 Week high
$19.44
52 Week high$19.44
52 Week low
$0.97
52 Week low$0.97

People also own

Based on the portfolios of people who own TRAW. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Cenntro Inc.
Castor Maritime
Ocugen, Inc
Tonix Pharmaceuticals
Toro
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.